Further PBS constraints predicted

INDUSTRY experts have warned bigger changes are ahead for the pharmaceutical industry, arguing the Federal Government’s decision to have Cabinet vet all PBAC recommendations to list medications on the PBS signals it is keen to pursue greater savings.